CYDEPS – Dose escalation pain study
The CYDEPS clinical trial is investigating the use of a medical cannabis product as a potential treatment for chronic back and/or neck pain.
The study is a single arm, open label clinical study which means everyone who participates will receive the experimental medication (there is no placebo).
The clinical study will run for approximately 5-6 weeks, and will include 8 study visits to a medical clinic over this time, each time seeing the study doctor. The clinical study is open to eligible participants in Sydney.
TO BE ELIGIBLE YOU MUST:
- Be aged 18-75
- Have a history of chronic neck and/or back pain for at least 3 months
- Tried treatment with over the counter (OTC) treatments such as paracetamol and ibuprofen which haven’t worked
ACRN- Australian Clinical Research Network
Maroubra, NSW, Australia, 2035
Contact: Mark Arya (02) 83470645
Study Coordinator (02) 83470645
Holdsworth House Medical Practice
Sydney, NSW, Australia
Contact: Patient Recruitment Coordinator
Email; email@example.com PH: (02)803810